NO20031215D0 - Difosfonatlösninger - Google Patents

Difosfonatlösninger

Info

Publication number
NO20031215D0
NO20031215D0 NO20031215A NO20031215A NO20031215D0 NO 20031215 D0 NO20031215 D0 NO 20031215D0 NO 20031215 A NO20031215 A NO 20031215A NO 20031215 A NO20031215 A NO 20031215A NO 20031215 D0 NO20031215 D0 NO 20031215D0
Authority
NO
Norway
Prior art keywords
difosfonatlösninger
Prior art date
Application number
NO20031215A
Other languages
English (en)
Other versions
NO20031215L (no
Inventor
Gregory Paul Handreck
Wei Zhou
Russell John Tait
Original Assignee
Faulding F H & Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR0189A external-priority patent/AUPR018900A0/en
Priority claimed from AUPR4855A external-priority patent/AUPR485501A0/en
Application filed by Faulding F H & Co Ltd filed Critical Faulding F H & Co Ltd
Publication of NO20031215D0 publication Critical patent/NO20031215D0/no
Publication of NO20031215L publication Critical patent/NO20031215L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
NO20031215A 2000-09-18 2003-03-17 Difosfonatlösninger NO20031215L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR0189A AUPR018900A0 (en) 2000-09-18 2000-09-18 Pamidronate solution
AUPR4855A AUPR485501A0 (en) 2001-05-10 2001-05-10 Stable injectable solutions
PCT/AU2001/001171 WO2002022136A1 (en) 2000-09-18 2001-09-18 Diphosphonate solutions

Publications (2)

Publication Number Publication Date
NO20031215D0 true NO20031215D0 (no) 2003-03-17
NO20031215L NO20031215L (no) 2003-05-16

Family

ID=25646444

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031215A NO20031215L (no) 2000-09-18 2003-03-17 Difosfonatlösninger

Country Status (10)

Country Link
US (3) US20040082545A1 (no)
EP (2) EP1318818A4 (no)
KR (1) KR20030043931A (no)
CN (1) CN1441674A (no)
AU (1) AU2001293473A1 (no)
CA (1) CA2406446A1 (no)
NO (1) NO20031215L (no)
PL (1) PL360910A1 (no)
TW (1) TW200418494A (no)
WO (1) WO2002022136A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY141763A (en) * 2003-09-18 2010-06-30 Novartis Ag Pharmaceutical products comprising bisphosphonates
WO2006100687A1 (en) * 2005-03-24 2006-09-28 Dabur Pharma Ltd. Disodium pamidronate aqueous formulation
US7605148B2 (en) * 2007-04-16 2009-10-20 Aurobindo Pharma Ltd. Aqueous oral solution of bisphosphonic acid
EP2363111A1 (en) * 2010-03-01 2011-09-07 Combino Pharm, S.L. Stable pharmaceutical composition comprising bisphosphonate
AR075721A1 (es) * 2010-03-05 2011-04-20 Eriochem Sa Composicion farmaceutica que comprende una solucion de acido zoledronico.
WO2011127629A1 (zh) * 2010-04-16 2011-10-20 台湾东洋药品工业股份有限公司 双磷酸注射液医药产品及其制法
CN116077446A (zh) * 2022-12-16 2023-05-09 上药东英（江苏）药业有限公司 一种雷贝拉唑钠冻干粉针剂及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7612534L (sv) * 1975-12-01 1977-06-02 Henkel & Cie Gmbh Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
US4304734A (en) * 1980-10-16 1981-12-08 Vysoka Skola Chemicko-Technologicka 6-Amino-1-hydroxyhexylidene diphosphonic acid, salts and a process for production thereof
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
US5219556A (en) * 1990-07-09 1993-06-15 Mallinckrodt Medical, Inc. Stabilized therapeutic radiopharmaceutical complexes
US5167816A (en) * 1990-08-20 1992-12-01 Abbott Laboratories Sterile coupling device for drug container
DE4228552A1 (de) * 1992-08-27 1994-03-03 Boehringer Mannheim Gmbh Diphosphonsäuren und deren Salze enthaltende Arzneimittel
US5780455A (en) * 1994-08-24 1998-07-14 Merck & Co., Inc. Intravenous alendronate formulations
JP3672342B2 (ja) * 1994-09-26 2005-07-20 アステラス製薬株式会社 ビスホスホン酸又はその誘導体を含有する注射液とその安定化方法、及び注射液アンプル
US5853894A (en) * 1997-02-03 1998-12-29 Cytonix Corporation Laboratory vessel having hydrophobic coating and process for manufacturing same
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
US6174873B1 (en) * 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs
US6794536B1 (en) * 1998-12-10 2004-09-21 Aesqen, Inc. Method for preparation of disodium pamidronate
US6160165A (en) * 1998-12-10 2000-12-12 Aesgen, Inc. Method for preparation of disodium pamidronate
EP1135397B1 (en) * 1998-12-10 2003-04-23 Aesgen, Inc. Method for preparation of disodium pamidronate
US6309596B1 (en) * 1998-12-15 2001-10-30 Bausch & Lomb Incorporated Treatment of contact lenses with aqueous solution comprising a biguanide disinfectant stabilized by a poloxamine
US6167369A (en) * 1998-12-23 2000-12-26 Xerox Company Automatic language identification using both N-gram and word information
HUP0203437A3 (en) * 1999-03-22 2003-07-28 Immugen Pharmaceuticals Inc So Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases
US6211169B1 (en) * 1999-09-29 2001-04-03 Aesgen, Inc. Stable calcitriol solution for packaging into vials
EP1136069A1 (en) * 2000-03-21 2001-09-26 SPA SOCIETA' PRODOTTI ANTIBIOTICI S.p.A. Pharmaceutical compositions containing clodronates for high local tolerance intramuscular administration
DE20106394U1 (de) * 2001-04-11 2001-08-09 Helm Pharmaceuticals Gmbh Pharmazeutische Zubereitung
HUP0400087A3 (en) * 2001-05-02 2007-05-29 Sicor Inc Injectable pamidroate disodium

Also Published As

Publication number Publication date
WO2002022136A1 (en) 2002-03-21
US20060154900A1 (en) 2006-07-13
EP1318818A4 (en) 2004-09-29
AU2001293473A1 (en) 2002-03-26
CA2406446A1 (en) 2002-03-21
EP1671638A1 (en) 2006-06-21
NO20031215L (no) 2003-05-16
CN1441674A (zh) 2003-09-10
US20040082545A1 (en) 2004-04-29
TW200418494A (en) 2004-10-01
EP1318818A1 (en) 2003-06-18
PL360910A1 (en) 2004-09-20
KR20030043931A (ko) 2003-06-02
US20060154898A1 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
ATE290000T1 (de) Muscarinagonisten
ATE252099T1 (de) Biarylcarboxamide
DE10136334B8 (de) Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATE312098T1 (de) Thiazinoxazolidinon
FI20000570A (fi) Monimurtojakajainen esijakaja
ATA2932001A (de) Schneefräse
DE50102988D1 (de) Bodenwischer
DE50104056D1 (de) Gewichtsmanschette
DE50100710D1 (de) Wischblatt
ATE262530T1 (de) Indolochinazolinone
ATE298751T1 (de) 7-oxopyridoryrimidine
DE50104651D1 (de) Fahrzeugfaltverdeck
DE10192638T1 (de) Bohrstangenladevorrichtung
ATE509008T1 (de) Sulfonylguanidine
DE10196064T1 (de) Halbleiterfotodektionsgerät
DE50100817D1 (de) Kugelgelenk
DE50011511D1 (de) Blowby-Heizung
ATE476423T1 (de) Benzoylpyridazine
DE50007634D1 (de) Kardioplegieballonkatheter
DE10052925B4 (de) Schaukelbett
DE10085445T1 (de) Drahterodierbearbeitungseinrichtung
DE10195909T1 (de) Viehfüttervorrichtung
DE10195992T1 (de) Oberflächenendbearbeitungsbelag
NO20031215D0 (no) Difosfonatlösninger
ATE284887T1 (de) Thienopyrrolidinone

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application